Aileron Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aileron Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from Q1 2020 to Q1 2023.
  • Aileron Therapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $13K, a 13.3% decline year-over-year.
  • Aileron Therapeutics, Inc. annual Depreciation for 2023 was $49K, a 71% decline from 2022.
  • Aileron Therapeutics, Inc. annual Depreciation for 2022 was $169K, a 39.7% increase from 2021.
  • Aileron Therapeutics, Inc. annual Depreciation for 2021 was $121K, a 25.8% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $13K -$2K -13.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q1 2022 $134K $15K +$13K +650% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $121K $91K +$81K +810% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $40K $15K +$1K +7.14% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $39K $13K -$56K -81.2% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $95K $2K -$68K -97.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $163K $10K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $14K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $69K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $70K Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.